EMEA-001072-PIP01-10-M04

Table of contents

Key facts

Invented name
Lemtrada
Active substance
alemtuzumab
Therapeutic area
Neurology
Decision number
P/0269/2020
PIP number
EMEA-001072-PIP01-10-M04
Pharmaceutical form(s)
Concentrate for solution for infusion
Condition(s) / indication(s)
Treatment of multiple sclerosis
Route(s) of administration
Intravenous use
Contact for public enquiries
Genzyme Europe B.V.

Tel: +49 (0) 800 52 52 010
E-mail: medinfo.de@sanofi.com

Decision type
PM: decision on the application for modification of an agreed PIP

Decision

Related content

How useful was this page?

Add your rating